On this HVAD, our colleagues share perspectives on how an HIV vaccine can be developed with the people it seeks to benefit most.
This test sensitively quantifies diverse strains of HIV to advance vaccine and cure research.
Nkengasong was a founding leader of PEPFAR and has served on IAVI’s board of directors.
HVTN, NIAID, and Moderna partner on trial of HIV Env trimers designed by IAVI's William Schief.
New TB vaccines are our best hope for a world without TB — it’s time to step up and finally make them a reality.
Using the power of social media to illuminate the urgent need for sustainable TB vaccine R&D
The archbishop advocated for the human rights of people living with HIV and tuberculosis
Strengthening research and science leadership capacity of African researchers
The call is endorsed by a global coalition advocating for a fully funded and resourced TB vaccine pipeline by 2023
IAVI and African Vaccine Manufacturing Initiative host virtual forum